Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer

logo
Natco Pharma Ltd.
09 Feb 2018
932.55
3.25%
HDFC Securities
Natco Pharma Ltd Q3FY18 results comment Revenue grew by 31.76% to Rs. 562.2 Cr in Q3FY18 when compared to the previous quarter. On the other hand, it decreased by 16.08% when compared with Q3FY17.
Natco Pharma Ltd. has an average target of 845.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended